Compass Therapeutics, Inc. (CMPX) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 16.7% |
| FCF Growth (YoY) | 9.5% |
| Price / Book | 2.60 |
| Price / Sales | 331.78 |
| FCF Yield | -23.9% |
| Altman Z-Score | 8.58 (safe) |
| Sector P/E (Healthcare) | 21.7 |
CMPX overview · CMPX earnings · CMPX KPIs · CMPX investor relations · CMPX ownership · CMPX peers · CMPX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.